© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
The Cooper Companies, Inc. (COO) stock declined over -1.01%, trading at $80.10 on NASDAQ, down from the previous close of $80.92. The stock opened at $80.95, fluctuating between $79.76 and $81.47 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Feb 05, 2026 | 80.95 | 81.47 | 79.76 | 80.10 | 1.8M |
| Feb 04, 2026 | 80.16 | 82.11 | 79.53 | 80.92 | 1.8M |
| Feb 03, 2026 | 80.39 | 81.83 | 78.79 | 79.33 | 1.05M |
| Feb 02, 2026 | 81.24 | 81.37 | 79.70 | 80.65 | 1.78M |
| Jan 30, 2026 | 80.37 | 81.54 | 80.29 | 81.38 | 1.55M |
| Jan 29, 2026 | 80.86 | 81.01 | 79.61 | 80.37 | 2.04M |
| Jan 28, 2026 | 80.76 | 81.19 | 80.09 | 80.48 | 1.12M |
| Jan 27, 2026 | 80.38 | 81.31 | 80.00 | 80.70 | 1.46M |
| Jan 26, 2026 | 81.52 | 81.61 | 80.53 | 80.90 | 1.29M |
| Jan 23, 2026 | 82.27 | 82.52 | 80.82 | 81.29 | 1.46M |
| Jan 22, 2026 | 82.23 | 83.79 | 82.23 | 82.80 | 2.6M |
| Jan 21, 2026 | 81.35 | 83.10 | 81.15 | 82.54 | 1.41M |
| Jan 20, 2026 | 81.26 | 81.65 | 80.24 | 80.61 | 2.6M |
| Jan 16, 2026 | 82.31 | 82.74 | 81.98 | 82.37 | 3.48M |
| Jan 15, 2026 | 81.88 | 82.47 | 80.69 | 82.31 | 2.42M |
| Jan 14, 2026 | 81.43 | 81.96 | 80.11 | 81.69 | 2.69M |
| Jan 13, 2026 | 83.50 | 84.05 | 81.19 | 81.70 | 1.6M |
| Jan 12, 2026 | 84.00 | 84.36 | 82.94 | 83.23 | 3.23M |
| Jan 09, 2026 | 83.13 | 83.88 | 82.11 | 83.45 | 2.51M |
| Jan 08, 2026 | 82.87 | 84.26 | 82.70 | 83.13 | 2.45M |
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
| Employees | 16000 |
| Beta | 1.03 |
| Sales or Revenue | $4.09B |
| 5Y Sales Change% | -0.587% |
| Fiscal Year Ends | October |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |